This webinar will focus on how biochemical engineering developed in response to the need for large-scale production of antibiotics in the 1940s and 50s, even though fermentation provided a route to many industrial organic chemicals prior to their production from petroleum.
SBE is a global technological community that promotes the integration of engineering with biology and realize its benefits through bioprocessing, biomedical, and biomolecular applications. SBE provides opportunities for interaction of engineers and scientists, develops products and services bring value to the broad biological engineering community, and infuses awareness of biological engineering among all functions and activities of AIChE.
The FP&BE division coordinates AIChE's activities in the fields of food, pharmaceuticals, and bioengineering.
The Forest Bioproducts Division promotes knowledge sharing and networking on topics dealing with products obtained from forest resources and other lignocellulosic materials.
Cellulases are of considerable current interest for converting the cellulosic content of biomass to fermentable sugars for biofuels production.
For the past two decades the capability of protein engineers to devise clever tumor-targeting molecules has outstripped our understanding of how these agents distribute through the body and permeate through tumors.
Micro- and nanoscale technologies are emerging as powerful tools for controlling the interaction between cells and their surroundings for biological studies, tissue eng
Dr. Holtzapple describes the challenges of providing energy to a growing world. To address energy needs, he shows how the MixAlco process converts waste biomass into bio-gasoline.
Dr. Langer discusses the involvement of engineering in health care, from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.
This webinar puts the complexity of malting and brewing into readily accessible terms.
Stem cells have become a promising cell source in the tissue engineering field.
We engineer designer fusion proteins that combine domains and functions from unrelated proteins and enzymes.
As cellular therapies are advancing through clinical development and getting closer to market, close collaborations between stem cell biologists, clinical cell processing technologists, and bioengineers will be required for effective commercializa
Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations.